Sponsored by

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 1976 to 2000 of about 5940

Previous 25

Website Changes

02/21/2015

Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastoma.

02/21/2015

End of the road: confounding results of the CORE trial terminate the arduous journey of cilengitide for glioblastoma

02/13/2015

Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma

02/10/2015

Could There Be a Gleevec for Brain Cancer?

02/10/2015

"Historic Moment"

02/09/2015

Dr. Howard Fine Named Founding Director of the Brain Tumor Center at NewYork-Presbyterian Hospital/Weill Cornell Medical Center

02/04/2015

02/02/2015

Dr. Howard Fine moved to Cornell!

01/31/2015

One Dose, Then Surgery: A New Way to Test Brain Tumor Drugs

01/31/2015

Helmet-like device treats recurrent brain cancer

01/31/2015

Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis.

01/24/2015

Could brain tumour survivors help unlock cancer cure?

01/22/2015

01/22/2015

Birth Control Pill Risks May Now Include Brain Cancer

01/20/2015

CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results in Glioblastoma Multiforme (Brain Cancer)

01/15/2015

FDA reports one death, many ill after receiving intravenous fluids meant for training purposes

12/29/2014

FDA approves Opdivo for advanced melanoma

12/26/2014

The IBTA Newsletter

12/21/2014

Novocure Announces Optune Now Available at more than 150 Leading Cancer Centers across the United States

12/21/2014

Neuro-oncologists discover cancer cells can burn acetate for fuel

12/17/2014

Novogen Announces Breakthrough Discovery in the Treatment of Melanoma

12/17/2014

At a Turning Point: Novel Therapeutic Developments in Glioblastoma Multiforme (GBM) Research : Conference posted online!

12/16/2014

MUSELLA FOUNDATION AWARDS BRAIN TUMOR RESEARCH GRANT

12/10/2014

Study shows certain brain tumors may run in families

12/02/2014

Novocure Announces FDA Approval of an IDE Supplement Allowing All Control Patients in its Phase III Trial in Newly Diagnosed GBM to Cross Over to Receive Tumor Treating Fields

Our privacy / cookie policy has changed.
Click HERE to read it!